source
- Bayer wins FDA approval for stroke prevention drug SunharboBayer’s asundexian won FDA approval to reduce the risk of stroke in people who recently had a mild-to-moderate non-cardioembolic ischemic stroke or a high-risk transient ischemic attack. The agency…Endpoints · 57m ago↗ source
- Third Rock Ventures commits up to $2.16 billion to AI-driven Chinese biotech Funnel BiosciencesThird Rock Ventures disclosed a partnership with Chinese biotech Funnel Biosciences, committing up to $2.16 billion to support its AI-driven biologics platform. The agreement includes a research c…